<?xml version="1.0" encoding="UTF-8"?>
<p>We selected a case-control study on 423 cases and 465 healthy controls. The demographics of the cohorts are given in 
 <xref rid="tab1" ref-type="table">Table 1</xref>. Patients diagnosed with Parkinson's disease by two neurologists according to the revised clinical diagnostic criteria were enrolled from the Neurology Clinic of the Affiliated Hospital of Qingdao University, China, from January 2016 to March 2019. The clinical diagnostic criteria for Parkinson's disease are bradykinesia in combination with either rest tremor, rigidity, or both, no absolute exclusion criteria, at least two support criteria, and no warning signs [
 <xref rid="B16" ref-type="bibr">16</xref>]. None of the patients had a family history of Parkinsonism, neuropathy, or psychosis conditions and none of them were related. Healthy controls were selected from the same hospital physical examination center. The exclusion criteria were Parkinson's disease, Alzheimer's disease, dementia, stroke and epilepsy, diabetes, hypertension, or other Parkinson's disease risk-related diseases. This study was verified and approved by the Ethics Committee of the Affiliated Hospital of Qingdao University. All subjects gave signed informed consent before blood collection and the study was performed according to the national ethical standards and the Code of Ethics of the World Medical Association (Declaration of Helsinki) for human genome research.
</p>
